TL;DR
This retrospective study of over 5,000 frozen-thawed embryo transfer (FET) cycles found that hormone replacement treatment (HRT) significantly improves implantation and clinical pregnancy rates compared to natural or semi-HRT cycles. Crucially, the study suggests that spontaneous ovulation during an HRT cycle can be detrimental to pregnancy outcomes, recommending careful monitoring and potential cancellation of ovulatory HRT cycles.
What Problem Does This Paper Address?
Assisted reproductive technologies (ART), particularly in vitro fertilization (IVF), often involve cryopreservation of embryos. Frozen-thawed embryo transfer (FET) is a crucial step in maximizing pregnancy rates and minimizing risks associated with fresh embryo transfers, such as ovarian hyperstimulation syndrome and multiple births. However, the success of FET is highly dependent on the receptivity of the endometrium, the uterine lining where the embryo implants. Preparing the endometrium for implantation is a complex process, and various protocols exist, including natural cycles (relying on the body's spontaneous ovulation) and hormone replacement treatment (HRT) cycles (where hormone levels are artificially controlled). Despite the widespread use of FET, there has been ongoing debate and conflicting results in the literature regarding which endometrial preparation protocol yields the best outcomes. This paper aims to clarify this by comparing the efficacy of natural, semi-HRT, and HRT cycles in a large cohort.
Methods
This study employed a retrospective cohort design, analyzing data from 5,414 FET cycles performed at a single academic hospital between January 2008 and December 2011. Patients were categorized into three groups based on their endometrial preparation protocol:
- Natural cycles: Monitored via transvaginal ultrasound and serum progesterone to time embryo transfer around natural ovulation.
- Semi-HRT cycles: Involved oral estradiol administration starting around cycle day 10-12, with dosage adjusted based on endometrial thickness, followed by intramuscular progesterone.
- HRT cycles: Utilized a structured oral estradiol regimen starting from cycle day 1, with dosage escalation, followed by intramuscular progesterone.
The primary outcome measures were implantation rate, clinical pregnancy rate, and live birth rate. Secondary analyses included peak endometrial thickness and the impact of ovulation within HRT cycles. Embryo quality was standardized by including only cycles with good-quality embryos. To minimize bias, only the first two FET cycles per patient were included.
Datasets
The study utilized data from 5,414 FET cycles collected retrospectively from patients undergoing treatment at the Reproductive Medicine Center of Tongji Hospital, Wuhan, China, between January 2008 and December 2011. This dataset represents a real-world clinical practice scenario.
Key Insights and Ideas
- HRT reigns supreme for FET: The most striking finding is that HRT significantly outperforms both natural and semi-HRT cycles in terms of implantation and clinical pregnancy rates. This suggests that a controlled hormonal environment is more conducive to successful embryo implantation in FET.
- Ovulation is a potential saboteur in HRT: The study's subanalysis revealed a critical insight: spontaneous ovulation during an HRT cycle negatively impacts pregnancy outcomes. This implies that the carefully orchestrated hormonal milieu of HRT is disrupted by natural ovulation, potentially altering the implantation window or endometrial receptivity.
- Thin endometrium doesn't preclude HRT success: Even in patients with thin endometria (≤8 mm), HRT still yielded better implantation and clinical pregnancy rates compared to natural or semi-HRT cycles. This is important because while HRT may not always significantly increase endometrial thickness, it appears to improve the quality of receptivity.
- Scheduling advantage of HRT: The authors highlight that HRT allows for predictable scheduling of embryo thawing and transfer, which is a significant practical advantage over natural cycles where timing can be more variable and dependent on individual follicular development.
Key Results
- Implantation Rate: HRT cycles achieved a significantly higher implantation rate (29.3%) compared to natural cycles (21.5%) and semi-HRT cycles (25.6%) (P=0.01).
- Clinical Pregnancy Rate: Similarly, HRT cycles resulted in a higher clinical pregnancy rate (48.7%) than natural cycles (36.1%) and semi-HRT cycles (42.7%) (P=0.01).
- Thin Endometrium (≤8 mm): Even in this subgroup, HRT showed superior implantation (27.8%) and clinical pregnancy rates (47.6%) compared to natural (22.1% and 33.7%) and semi-HRT (19.9% and 34.4%) cycles (P<0.01 for both).
- Ovulation in HRT: Patients undergoing HRT with spontaneous ovulation had significantly lower implantation rates (16.9%) and clinical pregnancy rates (26.3%) compared to anovulatory HRT patients (29.8% and 49.5%, respectively) (P<0.01 for both).
- Live Birth Rate: No significant differences were found in live birth rates among the three main groups, or between ovulatory and anovulatory HRT patients.
Limitations and Future Work
The authors acknowledge the retrospective nature of the study as a primary limitation, which means confounding factors may have influenced the results. They also note that the subanalysis of ovulatory HRT patients included a relatively small sample size (76 cycles), and a prospective observational study with a larger sample size is needed to confirm this finding. Future work should focus on prospective trials to validate these findings and further investigate the mechanisms by which ovulation negatively impacts HRT cycles. Additionally, exploring strategies to reliably suppress ovulation in HRT cycles while maintaining endometrial receptivity would be a valuable area of research. The study also suggests that while HRT may not always thicken the endometrium, its benefit in improving receptivity warrants further investigation, especially in patients with thin endometria.
Summary updated